Injection drug network characteristics as a predictor of injection behaviour.
Hepatitis C
injecting drug-users (IDUs)
surveillance
transmission
Journal
Epidemiology and infection
ISSN: 1469-4409
Titre abrégé: Epidemiol Infect
Pays: England
ID NLM: 8703737
Informations de publication
Date de publication:
01 2019
01 2019
Historique:
entrez:
8
5
2019
pubmed:
8
5
2019
medline:
28
3
2020
Statut:
ppublish
Résumé
Social network characteristics of people who inject drugs (PWID) have previously been flagged as potential risk factors for HCV transmission such as increased injection frequency. To understand the role of the injecting network on injection frequency, we investigated how changes in an injecting network over time can modulate injecting risk behaviour. PWID were sourced from the Networks 2 Study, a longitudinal cohort study of PWID recruited from illicit drug street markets across Melbourne, Australia. Network-related correlates of injection frequency and the change in frequency over time were analysed using adjusted Cox Proportional Hazards and Generalised Estimating Equations modelling. Two-hundred and eighteen PWID followed up for a mean (s.d.) of 2.8 (1.7) years were included in the analysis. A greater number of injecting partners, network closeness centrality and eigenvector centrality over time were associated with an increased rate of infection frequency. Every additional injection drug partner was associated with an increase in monthly injection frequency. Similarly, increased network connectivity and centrality over time was also associated with an increase in injection frequency. This study observed that baseline network measures of connectivity and centrality may be associated with changes in injection frequency and, by extension, may predict subsequent HCV transmission risk. Longitudinal changes in network position were observed to correlate with changes in injection frequency, with PWID who migrate from the densely-connected network centre out to the less-connected periphery were associated with a decreased rate of injection frequency.
Identifiants
pubmed: 31063105
pii: S095026881900061X
doi: 10.1017/S095026881900061X
pmc: PMC6518653
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e173Références
Hepatology. 1999 Mar;29(3):908-14
pubmed: 10051497
Acta Gastroenterol Belg. 2000 Apr-Jun;63(2):147-53
pubmed: 10925449
Soc Sci Med. 2001 Mar;52(6):967-78
pubmed: 11234869
J Infect Dis. 2002 Dec 1;186(11):1558-64
pubmed: 12447730
J Gastroenterol Hepatol. 2004 Oct;19(10):1114-20
pubmed: 15377287
Public Health. 2005 Dec;119(12):1111-5
pubmed: 16214189
J Viral Hepat. 2005 Nov;12(6):655-62
pubmed: 16255768
J Acquir Immune Defic Syndr. 2006 Apr 1;41(4):493-503
pubmed: 16652059
Am J Trop Med Hyg. 2006 Jun;74(6):1111-6
pubmed: 16760529
Addiction. 2006 Oct;101(10):1499-508
pubmed: 16968352
BMC Public Health. 2006 Sep 13;6:229
pubmed: 16970811
J Viral Hepat. 2007 Mar;14(3):213-20
pubmed: 17305887
Addiction. 2007 Nov;102(11):1730-9
pubmed: 17935581
J Infect Dis. 2007 Nov 15;196(10):1474-82
pubmed: 18008226
Hepatology. 2008 Dec;48(6):1746-52
pubmed: 18844233
J Infect. 2009 May;58(5):375-82
pubmed: 19328555
Nature. 2009 Oct 8;461(7265):798-801
pubmed: 19759533
J Infect Dis. 2009 Oct 15;200(8):1216-26
pubmed: 19764883
Gastroenterology. 2010 Apr;138(4):1338-45, 1345.e1-7
pubmed: 20060832
PLoS One. 2010 Jun 23;5(6):e11170
pubmed: 20585651
J Theor Biol. 2012 Mar 21;297:73-87
pubmed: 22185979
Epidemiol Infect. 2013 Feb;141(2):402-11
pubmed: 22717190
Am J Public Health. 2013 Jan;103(1):e44-52
pubmed: 23153148
Hepatology. 2014 Feb;59(2):366-9
pubmed: 23873507
PLoS One. 2013 Nov 01;8(11):e78286
pubmed: 24223787
PLoS One. 2014 Feb 11;9(2):e88623
pubmed: 24523923
J Hepatol. 2014 Nov;61(1 Suppl):S45-57
pubmed: 25086286
Hepatology. 2014 Dec;60(6):1861-70
pubmed: 25163856
Virulence. 2016;7(2):201-8
pubmed: 26305706
Cochrane Database Syst Rev. 2017 Sep 18;9:CD012021
pubmed: 28922449
Sex Transm Dis. 1994 May-Jun;21(3):161-7
pubmed: 8073344
J Acquir Immune Defic Syndr Hum Retrovirol. 1996 Nov 1;13(3):273-80
pubmed: 8898673
J Acquir Immune Defic Syndr Hum Retrovirol. 1998;18 Suppl 1:S11-9
pubmed: 9663618
AIDS. 1998 Aug 20;12(12):1529-36
pubmed: 9727575